IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 221 filers reported holding IVERIC BIO INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,997,375 | +60.0% | 186,706 | +34.0% | 1.18% | +57.3% |
| Q3 2022 | $2,499,000 | +165.9% | 139,315 | +42.5% | 0.75% | +185.6% |
| Q2 2022 | $940,000 | -23.7% | 97,745 | +33.5% | 0.26% | -4.4% |
| Q1 2022 | $1,232,000 | +0.7% | 73,196 | 0.0% | 0.28% | +10.4% |
| Q4 2021 | $1,224,000 | -31.6% | 73,196 | -33.6% | 0.25% | -4.6% |
| Q3 2021 | $1,790,000 | +9.7% | 110,231 | -57.4% | 0.26% | +11.1% |
| Q2 2021 | $1,632,000 | +119.9% | 258,580 | +115.3% | 0.24% | +109.8% |
| Q1 2021 | $742,000 | +19.7% | 120,075 | +33.9% | 0.11% | +3.7% |
| Q4 2020 | $620,000 | – | 89,665 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |